Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-K/AAmendment to a previously filed 8-KOct 28, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 28, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 27, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 25, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 19, 2010View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerOct 13, 2010Download DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECOct 12, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 5, 2010View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerSep 28, 2010Download DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Sep 24, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 24, 2010View HTMLDownload DOCDownload PDFDownload XLS
3Initial filing by director officer or owner of more than ten percent.Sep 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 24, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 24, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 22, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 15, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 9, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 9, 2010View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderSep 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 8, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 2, 2010View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Sep 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 1, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 31, 2010View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-123

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information